• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TORAX MEDICAL, INC. 1.5T LINX, 17 BEADS; ANTI-REFLUX IMPLANT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TORAX MEDICAL, INC. 1.5T LINX, 17 BEADS; ANTI-REFLUX IMPLANT Back to Search Results
Model Number LXMC17
Device Problems Device Appears to Trigger Rejection (1524); Appropriate Term/Code Not Available (3191); Patient Device Interaction Problem (4001)
Patient Problems Dysphagia/ Odynophagia (1815); Hypoxia (1918)
Event Date 08/01/2022
Event Type  malfunction  
Event Description
It was reported via clinical trial patient (b)(6) experience, decreased oxygen level.Relationship to study device: not related.
 
Manufacturer Narrative
(b)(4).Date of event: exact day unknown.Assume the first day of the month the event took place.Lot number was received and dhr is pending review.When the review is completed, a supplemental medwatch will be sent with a summary of the evaluation.Additional information received: patient identifier: (b)(6).(b)(6) medical center.Sex: female.Age (at time of consent): 56 years.Country of event: us.Model: lxmc17.Device lot number: 28493.Date of surgery: (b)(6) 2022.Adverse event term: decreased oxygen level.Site awareness date: (b)(6) 2022.End date: (b)(6) 2022.Severity: mild.Is the adverse event serious? yes.Required in-patient hospitalization or prolongation of existing hospitalization: yes.Admission date: (b)(6) 2022 discharge date: (b)(6) 2022.Other intervention/treatment: yes.If other specify: increased oxygen delivery methods, pulmonary toilet.Outcome: recovered/resolved, relationship to study procedure : blank - possible.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
 
Manufacturer Narrative
(b)(4).Date sent: 9/21/2022 b2.
 
Manufacturer Narrative
(b)(4).Date sent: 10/5/2022 additional information received: relationship to study procedure : possible => probable awareness date : (b)(6) 2022 : (b)(6) 2022 start date : (b)(6) 2022 : (b)(6) 2022 admission date : blank : (b)(6) 2022 discharge date : blank: (b)(6) 2022 required in-patient hospitalization or prolongation of existing hospitalization : no : yes.Is the adverse event serious? (if yes, check all that apply) : no : yes.
 
Manufacturer Narrative
(b)(4); date sent: 10/27/2022.Investigation summary: an analysis of the product could not be performed since a physical sample was not received for evaluation.A manufacturing record evaluation was performed for the finished device 28493 batch number, and no non-conformances were identified.As part of our company quality system process, all devices are manufactured, inspected, and distributed to approved specifications.However, if the product is received at a later date, the investigation will be updated as applicable.Additional information received: end date : (b)(6) 2022.
 
Manufacturer Narrative
(b)(4).Additional information received: relationship to study device: probable.Relationship to primary study procedure: probable.Diagnostic imaging: yes.If event is serious and device related, according to the protocol and instructions for use, in the opinion of the investigator, is the adverse event expected/anticipated? : blank = n/a.Diagnostic imaging : no = yes.Outcome : blank = not recovered/not resolved.Relationship to study procedure : blank = probable.
 
Manufacturer Narrative
(b)(4).Date sent; 6/15/2023.Additional information received: end date : blank => 01 feb 2023.Outcome : not recovered/not resolved => recovered/resolved.Adverse event term: dysphagia.Relationship to study device: probable.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
1.5T LINX, 17 BEADS
Type of Device
ANTI-REFLUX IMPLANT
Manufacturer (Section D)
TORAX MEDICAL, INC.
4545 creek road
cincinnati OH
Manufacturer Contact
orla o'mahony
4188 lexington avenue north
shoreview 55126
329348013
MDR Report Key15462039
MDR Text Key306421272
Report Number3008766073-2022-00188
Device Sequence Number1
Product Code LEI
UDI-Device Identifier00855106005370
UDI-Public00855106005370
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P100049
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study
Reporter Occupation Other
Type of Report Initial,Followup,Followup,Followup,Followup
Report Date 06/15/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberLXMC17
Device Catalogue NumberLXMC17
Device Lot Number28493
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 09/07/2022
Initial Date FDA Received09/21/2022
Supplement Dates Manufacturer Received09/07/2022
09/22/2022
10/27/2022
01/03/2023
06/06/2023
Supplement Dates FDA Received09/21/2022
10/05/2022
10/27/2022
01/18/2023
06/15/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/30/2021
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age56 YR
Patient SexFemale
-
-